Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration-Reference-Cited by-同舟云学术

Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration

Published:2022-05-28 Issue:5 Volume:27 Page:525-544
ISSN:1083-7450
Container-title:Pharmaceutical Development and Technology
language:en
Short-container-title:Pharmaceutical Development and Technology

Author:

Akbari Jafar¹,Saeedi Majid¹,Ahmadi Fatemeh¹²,Hashemi Seyyed Mohammad Hassan¹²,Babaei Amirhossein¹²,Yaddollahi Sadra²,Rostamkalaei Seyyed Sohrab³⁴,Asare-Addo Kofi⁵^ORCID,Nokhodchi Ali⁶^ORCID

Affiliation:

1. Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

2. Student Research Committee, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

3. Department of Pharmaceutics, Faculty of Pharmacy, Islamic Azad University, Ayatollah Amoli Branch, Amol, Iran

4. Medicinal Plant Research Center, Faculty of Pharmacy, Islamic Azad University, Ayatollah Amoli Branch, Amol, Iran

5. Department of Pharmacy, University of Huddersfield, Huddersfield, UK

6. Pharmaceutical Research Laboratory, School of Life Sciences, University of Sussex, Brighton, UK

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10837450.2022.2084554

Reference196 articles.

1. SLN, NLC, LDC: State of the Art in Drug and Active Delivery

2. Abdelaziz HM, Freag MS, Elzoghby AO. 2019. Chapter 5 - Solid lipid nanoparticle-based drug delivery for lung cancer. In: Kesharwani P, editor. Nanotechnology-based targeted drug delivery systems for lung cancer. London: Academic Press; p. 95–121.

3. Formulation of Kaempferol in Nanostructured Lipid Carriers (NLCs): A Delivery Platform to Sensitization of MDA-MB468 Breast Cancer Cells to Paclitaxel

4. Ahmad N, Pandey M, Mohamad N, Chen XY, Amin MCIM. 2020. Chapter 21 - Hydrogels for pulmonary drug delivery. In: Dua K, Hansbro PM, Wadhwa R, et al., editors. Targeting chronic inflammatory lung diseases using advanced drug delivery systems. London: Academic Press; p. 441–474.

5. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-Processed Excipients: Advances and Future Trends;Intelligent Pharmacy;2024-02

2. History, introduction, and physiochemical properties of gold nanoparticles;Gold Nanoparticles for Drug Delivery;2024

3. Fundamentals of a targeted drug delivery system;Molecular Pharmaceutics and Nano Drug Delivery;2024

4. Novel Strategies Using Sagacious Targeting for Site-Specific Drug Delivery in Breast Cancer Treatment: Clinical Potential and Applications;Critical Reviews™ in Therapeutic Drug Carrier Systems;2024

5. Recent progress of nanomedicine in managing dry eye disease;Advances in Ophthalmology Practice and Research;2024-01